CG INVITES CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,495 KRW | -0.80% |
|
+2.46% | -10.09% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 38.64B 28.13M 2.21B | Sales 2023 | 4.88B 3.55M 279M | Capitalization | 208B 152M 11.91B |
|---|---|---|---|---|---|
| Net income 2022 | -23.87B -17.38M -1.37B | Net income 2023 | -48.92B -35.62M -2.8B | EV / Sales 2022 | 5.93 x |
| Net cash position 2022 | 11.83B 8.62M 677M | Net cash position 2023 | 12.29B 8.94M 703M | EV / Sales 2023 | 40.2 x |
| P/E ratio 2022 |
-10.1
x | P/E ratio 2023 |
-4.2
x | Employees | 68 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.55% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.80% | ||
| 1 week | +2.46% | ||
| Current month | +2.46% | ||
| 1 month | -18.99% | ||
| 3 months | -27.79% | ||
| 6 months | -0.99% | ||
| Current year | -10.09% |
1 week
2 395.00
2 560.00
1 month
2 350.003 100.00
Current year
2 350.004 385.00
1 year
2 350.005 140.00
3 years
2 350.008 730.00
5 years
2 350.0014 766.67
10 years
2 350.0019 794.87
| Managers | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Young-Joon Yoo
AUD | Comptroller/Controller/Auditor | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Jin-Woo Lee
BRD | Director/Board Member | 59 | 30/03/17 |
Kyung-Sook Cho
BRD | Director/Board Member | 64 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/06/24 | 2,495 | -0.80% | 98 046 |
| 07/06/24 | 2,515 | +0.60% | 207,526 |
| 05/06/24 | 2,500 | -0.99% | 242,002 |
| 04/06/24 | 2,525 | +4.34% | 298,814 |
| 03/06/24 | 2,420 | -0.62% | 163,092 |
End-of-day quote Korea S.E., June 09, 2024
More quotes
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.09% | 140M | |
| +47.37% | 765B | |
| -6.12% | 354B | |
| +20.34% | 331B | |
| +9.61% | 299B | |
| +18.87% | 248B | |
| -1.96% | 219B | |
| +11.11% | 216B | |
| +5.16% | 164B | |
| -2.14% | 162B |
- Stock Market
- Equities
- A083790 Stock